Msika A, Mathias V, Boudigou M, Chambon M, et al. FcgammaR3A polymorphism influences natural killer cell activation and response to anti-PD-L1 (avelumab) in gestational trophoblastic neoplasia. Am J Obstet Gynecol 2024 Oct 4:S0002-9378(24)01046.
PMID: 39370035